The DST Gene Epidermolysis Bullosa Simplex Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. Priced at 4400 AED, this test is designed to detect mutations in the DST gene, which are responsible for the autosomal recessive form of Epidermolysis Bullosa Simplex (EBS) type 2. EBS is a group of genetic conditions that result in fragile skin that blisters easily from minor injuries or friction. The DST gene plays a critical role in the formation and function of the skin and other tissues, and mutations in this gene can lead to the symptoms associated with EBS.
This test is particularly important for individuals who have a family history of EBS or have symptoms suggestive of the condition. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of genetic abnormalities in the DST gene. The results from this test can provide crucial information for diagnosis, allowing for appropriate management and care strategies to be implemented. Additionally, it can offer valuable insights for family planning decisions for those with a history of the condition. DNA Labs UAE provides this test with the aim of offering precise and reliable genetic testing services to help manage and understand hereditary conditions like EBS.
The "GRIN2A Gene Epilepsy with Neurodevelopmental Defects Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the GRIN2A gene, which have been linked to various forms of epilepsy accompanied by neurodevelopmental defects. This test is particularly crucial for individuals who exhibit symptoms of epilepsy along with cognitive, behavioral, or motor development issues, as it can provide a definitive genetic diagnosis. The GRIN2A gene plays a significant role in the functioning of NMDA receptors, which are vital for synaptic transmission and plasticity in the brain, influencing learning and memory. Mutations in this gene can disrupt these processes, leading to the aforementioned conditions.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any abnormalities in the GRIN2A gene. The results can offer valuable insights into the specific type of epilepsy and neurodevelopmental disorder the individual might have, guiding treatment decisions and management strategies. It can also provide information on the risk of passing the condition to future offspring, which is crucial for family planning.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the GRIN2A gene. While the price might seem high, the potential benefits of obtaining a precise diagnosis and the consequent tailored treatment plan can be invaluable for affected individuals and their families. DNA Labs UAE is equipped with state-of-the-art facilities and employs experts in genetic testing, ensuring high-quality services and reliable results.
The GABRA1 gene plays a crucial role in the normal functioning of the brain. Mutations in this gene are associated with several forms of epilepsy, including Childhood Absence Epilepsy Type 4 (CAE4), a condition characterized by frequent absence seizures that begin in childhood. These seizures involve brief episodes of staring and unresponsiveness, significantly impacting the child's quality of life and cognitive development.
To identify susceptibility to CAE4, genetic testing for mutations in the GABRA1 gene is available. Conducted at DNA Labs UAE, this specialized test offers a comprehensive analysis of the GABRA1 gene to detect mutations that may predispose an individual to this form of epilepsy. The test is a critical tool for early diagnosis, allowing for timely intervention and management of the condition.
The cost of the GABRA1 gene epilepsy susceptibility test is 4400 AED. This investment covers the genetic analysis and the professional interpretation of results, providing valuable insights into the individual's genetic predisposition to CAE4. Early detection through this test can lead to better management strategies, potentially improving the quality of life for those affected by this condition.
The GABRB3 gene plays a crucial role in the development and function of the brain, particularly in the regulation of neurotransmission. Mutations in this gene have been linked to various neurological conditions, including Epilepsy Childhood Absence Type 5 (ECAT5). This specific type of epilepsy is characterized by frequent absence seizures that begin in childhood, significantly affecting attention and learning.
To diagnose and manage ECAT5 effectively, genetic testing for mutations in the GABRB3 gene is essential. DNA Labs UAE offers a comprehensive genetic test designed to identify mutations in the GABRB3 gene that are associated with Epilepsy Childhood Absence Type 5. This test is a valuable tool for clinicians in confirming the diagnosis, which can then guide treatment decisions and genetic counseling.
The cost of the GABRB3 gene epilepsy genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the GABRB3 gene. The results of this test can provide crucial information for the effective management and treatment of individuals with ECAT5, offering them a better quality of life.
The CACNA1H gene plays a crucial role in the proper functioning of the body's cellular electrical signaling, which is essential for the normal operation of various physiological processes, including those in the brain. Mutations in the CACNA1H gene have been linked to epilepsy childhood absence type 6 (ECAT6), a specific form of epilepsy characterized by frequent, brief absence seizures that begin in childhood. These seizures involve short periods of staring and unresponsiveness, significantly impacting the child's quality of life and cognitive development.
To aid in the diagnosis and management of ECAT6, genetic testing for mutations in the CACNA1H gene is available. This test can confirm a diagnosis, help predict the course of the disease, and inform treatment decisions. Conducted at specialized facilities such as DNA Labs UAE, this genetic test involves analyzing the patient's DNA to identify mutations in the CACNA1H gene that are associated with the condition.
The cost of the CACNA1H gene epilepsy childhood absence type 6 susceptibility genetic test at DNA Labs UAE is 4400 AED. This price may reflect the comprehensive nature of the testing process, which includes the collection of a DNA sample, usually through a blood draw or cheek swab, followed by sophisticated genetic analysis in the laboratory. The result from this test not only helps in confirming the diagnosis but also plays a critical role in the personalized treatment planning, offering a targeted approach based on the individual's genetic makeup.
In summary, the CACNA1H gene epilepsy childhood absence type 6 susceptibility genetic test is a valuable diagnostic tool offered at DNA Labs UAE, with the potential to significantly impact the management and treatment of affected individuals by providing precise genetic insights into their condition.
The LGI1 Gene Epilepsy Familial Temporal Lobe Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the LGI1 gene that are associated with familial temporal lobe epilepsy type 1 (FTLE1). This condition is a form of epilepsy that typically affects families and is characterized by seizures originating in the temporal lobe of the brain. These seizures can manifest as sensory disturbances, emotional changes, or complex partial seizures that may progress to generalized tonic-clonic seizures.
The test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the LGI1 gene. Identifying mutations in this gene can confirm a diagnosis of FTLE1, which is crucial for tailoring treatment plans, managing symptoms more effectively, and providing genetic counseling for affected families.
The cost of the LGI1 Gene Epilepsy Familial Temporal Lobe Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the genetic analysis, the expertise required to interpret the results, and the potential life-changing impact that a precise diagnosis can have for patients and their families. It's an investment in understanding a genetic condition that affects not just the individual tested but can also have implications for their relatives, offering insights into inheritance patterns and risks for future generations.
The HCN2 gene, also known as the hyperpolarization-activated cyclic nucleotide-gated potassium channel 2, plays a significant role in the electrical activity of the heart and brain. Mutations in this gene have been linked to various neurological conditions, including certain forms of epilepsy. Epilepsy associated with the HCN2 gene involves a spectrum of seizure disorders, which can vary in severity and response to treatment.
To aid in the diagnosis and management of epilepsy potentially linked to the HCN2 gene, DNA Labs UAE offers a specialized genetic test. This test is designed to identify mutations in the HCN2 gene that may contribute to the development of epilepsy. By pinpointing the specific genetic alterations, healthcare providers can gain valuable insights into the condition, allowing for a more personalized approach to treatment and management.
The test is conducted with a sample of the patient's DNA, typically collected through a blood draw or a cheek swab. The sample is then analyzed in the laboratory using advanced genetic sequencing techniques to detect any mutations in the HCN2 gene.
The cost of the HCN2 related genetic test at DNA Labs UAE is 4400 AED. This investment can be pivotal for individuals and families seeking answers to unexplained seizure disorders, as it not only provides a clearer diagnosis but also opens the door to targeted treatment options and a better understanding of the condition's prognosis.
The GABRD gene epilepsy idiopathic generalized type 10 genetic test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the GABRD gene, which have been linked to epilepsy. Idiopathic generalized epilepsy (IGE) encompasses a group of epilepsy syndromes that do not have a clear cause and are characterized by generalized seizures. The GABRD gene plays a crucial role in encoding a component of the GABA receptor, which is essential for inhibiting neurotransmission in the brain. Mutations in this gene can disrupt normal brain function, leading to the development of epilepsy.
This genetic test is particularly valuable for individuals who have been diagnosed with epilepsy but do not have an identifiable cause for their condition. By pinpointing specific genetic mutations, healthcare providers can gain a better understanding of the nature of the epilepsy, which can inform treatment decisions and potentially lead to more personalized and effective management strategies.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the GABRD gene epilepsy idiopathic generalized type 10 genetic test is 4400 AED. This price reflects the comprehensive nature of the test, including the collection of a DNA sample, usually through a blood draw or cheek swab, the detailed analysis of the GABRD gene, and the provision of a report that interprets the results in the context of the patient's health and family history.
For individuals and families affected by idiopathic generalized epilepsy, this test represents a critical step towards understanding the genetic underpinnings of their condition and can guide more targeted and effective treatment approaches.
The CLCN2 gene epilepsy idiopathic generalized type 11 genetic test is a specialized diagnostic procedure designed to identify mutations in the CLCN2 gene, which have been associated with idiopathic generalized epilepsy type 11 (EIG11). This condition is a form of epilepsy characterized by various seizure types, including absence, myoclonic, and tonic-clonic seizures, without a clear cause. The CLCN2 gene plays a critical role in regulating chloride channels in neurons, and mutations can disrupt normal neuronal activity, leading to seizures.
This genetic test is crucial for individuals with a clinical diagnosis of idiopathic generalized epilepsy, as it can confirm the involvement of the CLCN2 gene mutation. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific mutations in the CLCN2 gene.
Conducted at DNA Labs UAE, a leading facility in genetic testing and diagnostics, the test offers a comprehensive analysis with reliable results. The cost of the test is set at 4400 AED, reflecting the advanced technology and expertise required to accurately identify the genetic variations associated with this form of epilepsy.
By confirming the genetic basis of the condition, the CLCN2 gene epilepsy idiopathic generalized type 11 genetic test can aid in the personalized management of the disorder, guiding treatment decisions and providing valuable information for family planning.
The SLC2A1 Gene Epilepsy idiopathic generalized type 12 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the SLC2A1 gene, which are associated with Epilepsy, idiopathic generalized type 12. This type of epilepsy is a genetic disorder characterized by seizures with no apparent cause, and it has been linked to variations in the SLC2A1 gene. The test plays a crucial role in the early detection and management of the condition, enabling healthcare providers to tailor treatment plans based on the genetic makeup of the individual.
Priced at 4400 AED, the test is conducted using a sample of the patient's DNA, typically extracted from a blood sample. The process involves advanced genetic sequencing techniques to meticulously analyze the SLC2A1 gene for specific mutations known to contribute to the development of epilepsy. The results from this test can provide valuable insights into the patient's condition, including the likelihood of developing epilepsy, potential response to treatments, and the risk of passing the condition on to future generations.
DNA Labs UAE is known for its state-of-the-art facilities and expertise in genetic testing, offering accurate and reliable results. The test is recommended for individuals with a family history of epilepsy or those who exhibit symptoms associated with the disorder, aiming to provide them with a clearer understanding of their condition and how best to manage it.
